Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Agios Pharmaceuticals (NQ: AGIO )

46.81 USD +0.99 (+2.17%)
Streaming Delayed Price Updated: 12:08 PM EDT, Oct 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 61,400
Open 46.00
Bid (Size) 46.78 (1)
Ask (Size) 46.85 (2)
Prev. Close 45.82
Today's Range 45.49 - 46.89
52wk Range 32.47 - 62.16
Shares Outstanding 58,951,469
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Agios To Present at September Investor Conferences
From GlobeNewswire News Releases
Agios Announces FDA Acceptance and Priority Review of New Drug Application for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
-- PDUFA Date Set for February 17, 2022 -- 
From GlobeNewswire News Releases

Performance

YTD
+5.68%
+5.68%
1 Month
+1.53%
+1.53%
3 Month
-17.49%
-17.49%
6 Month
-15.92%
-15.92%
1 Year
+32.70%
+32.70%

More News

Read More
Agios Reports Business Highlights and Second Quarter 2021 Financial Results
From GlobeNewswire News Releases
Agios to Webcast Conference Call of Second Quarter 2021 Financial Results on July 29, 2021
From GlobeNewswire News Releases
Agios Submits Marketing Authorisation Application to European Medicines Agency for Mitapivat for Treatment of Adults with Pyruvate Kinase Deficiency
From GlobeNewswire News Releases
Analysts Expect 42% Gains Ahead For The Holdings of WDNA
Tags ETFs
From ETF Channel
Agios Launches myAgios® Patient Support Services for Pyruvate Kinase Deficiency
From GlobeNewswire News Releases
7 Best Biotech Stocks to Buy in 2021 with Huge Upside
Tags AGIO NYSE:JNJ,NASDAQ:EXEL,NASDAQ:AGIO,NASDAQ:NVAX,NASDAQ:MRNA,NASDAQ:SAGE,NASDAQ:VRTX,NYSE:PFE EXEL
From InvestorPlace
Agios' Rare Anemia Drug Application Under FDA Priority Review
Tags News Anemia General
From Benzinga
We Did The Math FBT Can Go To $206
Tags ETFs
From ETF Channel
Agios Pharmaceuticals, inc (AGIO) Q2 2021 Earnings Call Transcript
Tags Market News AGIO
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.